SIG Q1 Report 2024

Revenue performance

• Volume growth in aseptic and chilled carton Bag-in-box & spouted pouch sales growth impacted by high Q1 2023 comparison No Group impact from resin escalator in Q1 
• Revenue €722 million
• (1.0)% reported
• 0.0% constant currency
• 0.0% constant currency & constant resin

Strategic investments to support future growth

• Transfer of Shanghai chilled plant to new stateof-the-art production facility at Suzhou Industrial Park. Construction of Indian sleeves plant well under way and completion expected by year-end

Aseptic filling technology innovation

• Speed up kits launched in India:
• 10% increase in output on installed single serve fillers
• increasing output with minimal associated capex for SIG or customer

Highlights

• Revenue growth at constant currency and constant resin 6.2%
• Strong aseptic carton volume growth
• Continue to win new filler contracts in liquid dairy and food
• High prior year bag-in-box & spouted pouch revenue comparison including equipment sales that were not repeated

In Numbers

• Adjusted EBITDA
• €155 million (Q1 2023: €175 m)
• Adjusted EBITDA margin
• 21.5% (Q1 2023: 24.0%)
• Adjusted net income
• €40 million (Q1 2023: €65 m)
• Net capital investment
• €(63) million (Q1 2023: €(87) m)
• Free cashflow
• €(101) million (Q1 2023: €(95) m)